Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging

Driven by the motivation for optimizing 64 Cu radiolabeling efficiency of nanoparticles for in vivo positron emission tomography (PET) imaging, a new strategy has been developed. This strategy involved a complete redesign of the nanoparticle system, utilizing macromolecular precursors that were preloaded with labeling sites and programmed for supramolecular assembly into discrete, functional nanoscale objects. A series of shell-crosslinked nanoparticles (SCKs) have been constructed by grafting a copper chelating agent (DOTAlysine) onto amphiphilic block copolymers PAA-b-PS, self assembling the functionalized block copolymer precursors into micelles, and crosslinking the micellar corona to afford the expected nanoobjects. These pre-DOTAlysine-SCKs showed impressive results on 64 Cu radiolabeling (∼ 400 copper atoms per spherical nanoparticle). Among the molecular imaging modalities, PET is widely used as a powerful diagnostic tool by clinicians and scientists. [1] Compared with other imaging methods, it bears the advantages of high sensitivity (the level of detection approaches 10 –11 M of tracer) and isotropism (i.e., ability to detect expres

[1]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[2]  M. Becker,et al.  Functionalized micellar assemblies prepared via block copolymers synthesized by living free radical polymerization upon peptide-loaded resins. , 2005, Biomacromolecules.

[3]  A. Eisenberg,et al.  Multiple Morphologies and Characteristics of “Crew-Cut” Micelle-like Aggregates of Polystyrene-b-poly(acrylic acid) Diblock Copolymers in Aqueous Solutions , 1996 .

[4]  C. Ling,et al.  Hyperthermia and gene therapy: Potential use of MicroPET imaging , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[5]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[6]  Karen L. Wooley,et al.  Shell crosslinked polymer assemblies: Nanoscale constructs inspired from biological systems , 2000 .

[7]  Arion F. Chatziioannou,et al.  Molecular imaging of small animals with dedicated PET tomographs , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  S. Cherry.  The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Wooley,et al.  Fundamental design aspects of amphiphilic shell-crosslinked nanoparticles for controlled release applications , 2001 .

[11]  V. Trubetskoy,et al.  Polymeric micelles as carriers of diagnostic agents. , 1999, Advanced Drug Delivery Reviews.

[12]  T. Kaden,et al.  Metal complexes of macrocyclic ligands. Part XXIII. Synthesis, properties, and structures of mononuclear complexes with 12‐ and 14‐membered tetraazamacrocycle‐N,N′,N″,N‴‐tetraacetic Acids , 1986 .

[13]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[14]  Lifeng Zhang,et al.  Multiple Morphologies of "Crew-Cut" Aggregates of Polystyrene-b-poly(acrylic acid) Block Copolymers , 1995, Science.

[15]  J. L. Turner,et al.  An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. , 2005, Biomacromolecules.

[16]  M. Welch,et al.  Radiometal-labeled agents (non-technetium) for diagnostic imaging. , 1999, Chemical reviews.

[17]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[18]  P. Price,et al.  The potential of positron-emission tomography to study anticancer-drug resistance , 2004, Nature Reviews Cancer.

[19]  R. Colin Garner,et al.  Big physics, small doses: the use of AMS and PET in human microdosing of development drugs , 2003, Nature Reviews Drug Discovery.

[20]  C. Hawker,et al.  Functionalization of Micelles and Shell Cross-linked Nanoparticles Using Click Chemistry , 2005 .

[21]  V. Sossi,et al.  Micropet imaging: in vivo biochemistry in small animals , 2005, Journal of Neural Transmission.

[22]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[23]  M. Welch,et al.  Labeling of Polymer Nanostructures for Medical Imaging: Importance of crosslinking extent, spacer length, and charge density. , 2007, Macromolecules.

[24]  M. Welch,et al.  MicroPET imaging with non-conventional isotopes , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[25]  C. Anderson,et al.  Copper chelation chemistry and its role in copper radiopharmaceuticals. , 2007, Current pharmaceutical design.

[26]  D. Maysinger,et al.  Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[27]  Suzanne V. Smith.  Molecular imaging with copper-64. , 2004, Journal of inorganic biochemistry.

[28]  Karen L. Wooley,et al.  Shell Cross-Linked Knedels: A Synthetic Study of the Factors Affecting the Dimensions and Properties of Amphiphilic Core-Shell Nanospheres , 1997 .

[29]  W. Weber.  Chaperoning drug development with PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Tomasz Kowalewski,et al.  Hydrogel-Coated Glassy Nanospheres: A Novel Method for the Synthesis of Shell Cross-Linked Knedels , 1997 .

[31]  Weijun Niu,et al.  Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. , 2004, Journal of medicinal chemistry.

[32]  Jason S. Lewis,et al.  Molecular imaging: The application of small animal positron emission tomography , 2002, Journal of cellular biochemistry. Supplement.

[33]  Vladimir P Torchilin,et al.  PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.

[34]  Samuel A Wickline,et al.  Molecular imaging, targeted therapeutics, and nanoscience , 2002, Journal of cellular biochemistry. Supplement.

[35]  H. Ghandehari,et al.  Nanocarriers for nuclear imaging and radiotherapy of cancer. , 2006, Current pharmaceutical design.

[36]  Jingli Wang,et al.  Positron Emission Tomography: applications in drug discovery and drug development. , 2005, Current topics in medicinal chemistry.

[37]  C. Wiele,et al.  Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status , 2004 .

[38]  Kai Qi,et al.  64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  Simone Weber,et al.  Small animal PET: aspects of performance assessment , 2004, European Journal of Nuclear Medicine and Molecular Imaging.